Reimbursement Intelligence Information

Since it was founded in 2005, Reimbursement Intelligence (RI) has established a cutting-edge approach to achieving reimbursement and access excellence for life sciences companies. From launch to expiry planning, RI offers a reimbursement roadmap to guide manufacturers through a product’s lifecycle. RI partners with pharmaceutical, biotech and device clients of all sizes, including 13 of the top 20 pharmaceutical and biotech companies. What differentiates RI is a unique integration of strategy and execution expertise—we help organizations ensure their access and reimbursement strategies are exceptional. RI’s market intelligence helps companies anticipate managed markets trends and changes, and translates these strategies into best-in-class sales, training, and communication programs.